Medical Cannabis Related News
Symtomax: innovation in European cannabis
Portugal-based cannabis producer Symtomax deploys industry experience and genetic expertise to deliver high-quality, market-leading products.
Symtomax has been granted approval by INFARMED, the Portuguese regulatory...
Fibromyalgia patients swapping opioids for CBD to manage pain
New research has shown that patients living with the chronic pain condition of fibromyalgia are swapping opioids for CBD in a bid to manage...
New data from UK Medical Cannabis Registry presented at symposium
Sapphire Medical Clinics has presented new data from the UK Medical Cannabis Registry at the 31st Annual International Cannabinoid Research Society Symposium on the...
LeafCann CEO elected to CIC Board and Chair of Standards Group
Elisabetta Faenza has been elected to the UK-based Cannabis Industry Council (CIC) Board and has been selected to Chair its Standards Group.
The CIC consists...
Association for the Cannabinoid Industry to expand EU Offering
The Association for the Cannabinoid Industry (ACI) has announced the opening of a new Brussels office as they expand their membership offering into the...
Researching cannabis-based drugs for COVID and glyblactoma multiforma
Global thought leaders in cannabis came together for the GCI Summit from 8 to 10 June which explored policy, research, investment and more across...
Campaigner requests meeting with PM to discuss NHS medical cannabis
Medical cannabis campaigner Hannah Deacon has delivered a letter to UK Prime Minister, Boris Johnson, requesting a meeting to discuss medical cannabis access on...
Taskforce proposes UK cannabinoid regulation changes
The Taskforce on Innovation, Growth and Regulatory Reform (TIGRR) has reported recommendations to the Prime Minister on how the UK can reshape regulation and...
Medical cannabis campaigners visit Westminster
Medical cannabis campaigners visited Westminster as part of a walk from Belfast to London to raise funds for the UK’s most vulnerable, chronically ill...
Whither the winds of the European cannabis industry post-pandemic?
The European Cannabis Association is setting its sights on harmonising the cannabis regulatory environment across the continent.
The COVID-19 pandemic is a generation- if not...
Cannabis research in Meir Hospital: Realistic innovation
Researchers at Meir Hospital are investigating the therapeutic potential of cannabis for a number of indications.
In the last few decades, the world has witnessed...
Towards a UK cannabis industry
Health Europa Quarterly (HEQ) speaks with Mike Barnes of Maple Tree Consultants and Ricardo Geada of Mackrell Solicitors about the need for a legal...
Licence applications for cannabis exports opened by Isle of Man Government
The Isle of Man Government has now opened licence applications for the production, distribution, and export of medical cannabis from the Island, expecting the...
UK prescription cannabis recalled that ‘may be contaminated with mould’
UK prescription cannabis supplier NOIDECS has recalled two batches of product and has advised patients not to use their prescription medicine after reports of...
Fluence expands in Israeli cannabis industry with LED lighting solutions
Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, has announced its implementations with...
GCI Summit: exploring cannabis and psychedelics
This week, the GCI Summit gives global leaders the opportunity to network with the best minds in cannabis and psychedelics.
Taking place from 8 to...
New council body launched to demand robust UK cannabis industry
A collective of organisations, businesses, and working groups have united to launch The Cannabis Industry Council – the first representative cannabis body dedicated to...
UK data highlights medical cannabis as an opioid crisis solution
New UK data has highlighted that medical cannabis could provide a solution to the opioid crisis as an alternative medicine for chronic pain patients.
UK...
Medical cannabis patients report improvements in anxiety, pain, and sleep
The outcomes of the first cohort of medical cannabis patients in the UK have demonstrated significant improvements in anxiety, pain, and sleep for medical...
Evidence, policy and regulation in medical cannabis
The Centre for Medicinal Cannabis hosted a crucial summit in April aimed at shaping the future of the UK’s medical cannabis sector.
On Thursday 15...
